A. Martínez

Platelet-lymphocyte and neutrophil-lymphocyte ratios are prognostic but not predictive of response to abiraterone acetate in metastatic castration-resistant prostate cancer.

E. Cánovas, Á. Borque, R. Aguilar, 2017 .

Early responses to enzalutamide in AR-V7 positive first line metastatic castration-resistant prostate cancer (mCRPC). A prospective SOGUG clinical trial: The PREMIERE study

M. Climent, E. Gallardo, B. Mellado, 2016 .

Role of the BRAF Mutations in the Microsatellite Instability Genetic Pathway in Sporadic Colorectal Cancer

M. Sanz-Casla, J. Cerdán, M. Herranz, 2007, Annals of Surgical Oncology.